Cargando…

Disparities in Rural Populations With Idiopathic Pulmonary Fibrosis

[Figure: see text]

Detalles Bibliográficos
Autores principales:	DeDent, Alison M., Collard, Harold R., Thakur, Neeta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians 2022
Materias:	Diffuse Lung Disease: Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470744/ https://www.ncbi.nlm.nih.gov/pubmed/35390330 http://dx.doi.org/10.1016/j.chest.2022.03.042

Ejemplares similares

PREDICTORS OF POST-COVID-19 PULMONARY FIBROSIS: A CASE SERIES
por: CÎRJALIU, R.-E., et al.
Publicado: (2022)

The Use of Genetic Information to Define Idiopathic Pulmonary Fibrosis in UK Biobank
por: Leavy, Olivia C., et al.
Publicado: (2023)

A CASE REPORT OF COMPLICATIONS IN A SURVIVOR OF SEVERE COVID-19: PULMONARY FIBROSIS AND LONG-TERM SUPPLEMENTAL OXYGEN REQUIREMENT
por: YANAMADALA, A.
Publicado: (2022)

CHILDHOOD-ONSET INTERSTITIAL LUNG DISEASE: A RARE CASE OF IDIOPATHIC, NONSPECIFIC INTERSTITIAL PNEUMONIA IN A TEENAGER
por: Cerro, Giuliana, et al.
Publicado: (2020)

Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and COPD: A Propensity-Matched Real-World Study
por: Nolan, Claire M., et al.
Publicado: (2022)

COVID-19 VACCINE-RELATED PNEUMONITIS
por: TSENG, CHENGTIN, et al.
Publicado: (2022)

PULMONARY ALVEOLAR PROTEINOSIS SUBMITTED A WHOLE LUNG LAVAGE AFTER COVID-19: A CASE REPORT
por: D'AMBROSIO, PAULA, et al.
Publicado: (2021)

ORGANIZING PNEUMONIA AS A SIDE EFFECT OF COVID-19 VACCINE
por: DADHWAL, R., et al.
Publicado: (2022)

DERMATOMYOSITIS AFTER COVID-19 PNEUMONIA
por: KHANAM, VERISHA, et al.
Publicado: (2022)

MORTALITY AND ITS PREDICTORS IN PATIENTS WITH COVID-19 WITH PREEXISTING INTERSTITIAL LUNG DISEASE
por: DUTT, N., et al.
Publicado: (2022)

ELECTRONIC VAPE-ASSOCIATED LUNG INJURY: A UNIQUE PRESENTATION
por: Hawk, Fahad, et al.
Publicado: (2020)

FIBROTIC PROTEASE 3 ANCA-ASSOCIATED VASCULITIS
por: Megri, Mohammed, et al.
Publicado: (2020)

AN UNUSUAL PRESENTATION OF NONSPECIFIC INTERSTITIAL PNEUMONIA
por: Matta, Atul, et al.
Publicado: (2020)

NOT ALL ARDS IS COVID: THE RISK OF PREMATURE CLOSURE AND THE VALUE OF MULTIDISCIPLINARY DISCUSSION
por: VARGAS, JORGE, et al.
Publicado: (2021)

THE PERFECT STORM: DIFFUSE ALVEOLAR HEMORRHAGE AFTER SARS-COV-2 INFECTION
por: WANG, EDWARD, et al.
Publicado: (2021)

THINKING BEYOND COVID-19: A CASE OF KRATOM-INDUCED PNEUMONITIS
por: MINICH, CORBYN, et al.
Publicado: (2021)

COVID-19 VACCINE UPTAKE IN AN INTERSTITIAL LUNG DISEASE CLINIC
por: LEAHY, AMY, et al.
Publicado: (2021)

OUTCOMES IN PATIENTS WITH SARCOIDOSIS DIAGNOSED WITH COVID-19
por: NADEEM, OWAIS, et al.
Publicado: (2021)

A CASE OF STEROID RESPONSIVE SEVERE PNEUMONIA RELATED TO IMMUNE-LIKE RECONSTITUTION INFLAMMATORY RESPONSE 3 MONTHS AFTER RITUXIMAB THERAPY FOR PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH STREPTOCOCCAL INFECTIONS
por: POURSHAHID, SEYEDMOHAMMAD, et al.
Publicado: (2021)

A CASE OF SEVERE HYPOXEMIA AND HEMOPTYSIS SECONDARY TO E-CIGARETTE AND VAPING PRODUCT USE-ASSOCIATED LUNG INJURY IN COVID-19 ERA
por: POLISETTY, LAKSHMI, et al.
Publicado: (2021)

ORGANIZING PNEUMONIA FOLLOWING COVID-19: A REPORT OF 8 CASES
por: BETHLEM, MARCOS, et al.
Publicado: (2021)

A CASE OF SEVERE E-CIGARETTE OR VAPING PRODUCT USE-ASSOCIATED LUNG INJURY IN THE TIME OF COVID-19
por: WASSERMAN, EVAN, et al.
Publicado: (2021)

AGGRESSIVE AND RAPID NASCENT HONEY COMBING DURING ACUTE COVID-19 INFECTION: A CASE REPORT
por: JOSHI, V., et al.
Publicado: (2022)

EXTENSION OF STEROID THERAPY FOR POST-COVID-19 FIBROTIC LUNG SEQUALAE
por: TOUMAN, A., et al.
Publicado: (2022)

WITHDRAWN
Publicado: (2022)

PUTTING THE "SARS” IN "SARS-COVID-19": A CASE OF SARCOID-LIKE INFLAMMATORY REACTION AFTER COVID-19 VACCINATION
por: JAFRI, MUSTAFA HUS, et al.
Publicado: (2022)

COVID-19 PNEUMONIA AND PERICARDITIS IN A PATIENT WITH UNTREATED CYSTIC LUNG DISEASE
por: KOZLIK, ANN, et al.
Publicado: (2022)

MULTISYSTEM SARCOIDOSIS ASSOCIATED WITH THE COVID-19 MRNA VACCINE
por: MITMA, ANGEL A, et al.
Publicado: (2022)

Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry
por: Snyder, Laurie D, et al.
Publicado: (2020)

Idiopathic pulmonary fibrosis: A guide for nurse practitioners
por: Vega-Olivo, Michelle, et al.
Publicado: (2018)

Clinical use of nintedanib in patients with idiopathic pulmonary fibrosis
por: Hajari Case, Amy, et al.
Publicado: (2017)

Metabolic heterogeneity of idiopathic pulmonary fibrosis: a metabolomic study
por: Zhao, Yidan D, et al.
Publicado: (2017)

Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
por: Kolb, Martin, et al.
Publicado: (2017)

Cluster analysis of transcriptomic datasets to identify endotypes of idiopathic pulmonary fibrosis
por: Kraven, Luke M, et al.
Publicado: (2023)

Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis
por: Kreuter, Michael, et al.
Publicado: (2017)

Neutrophil lymphocyte ratio as an indicator for disease progression in Idiopathic Pulmonary Fibrosis
por: Achaiah, Andrew, et al.
Publicado: (2022)

Topological data analysis identifies molecular phenotypes of idiopathic pulmonary fibrosis
por: Shapanis, Andrew, et al.
Publicado: (2023)

In-Hospital Mortality in Patients with Idiopathic Pulmonary Fibrosis: A US Cohort Study
por: Durheim, Michael T., et al.
Publicado: (2019)

A qualitative study of informal caregivers’ perspectives on the effects of idiopathic pulmonary fibrosis
por: Belkin, Amanda, et al.
Publicado: (2014)

Rationale for and design of the Idiopathic Pulmonary Fibrosis–PRospective Outcomes (IPF-PRO) registry
por: O'Brien, Emily C, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jtthiiins8fmj9pmfi3tdupjpt